title: [Etiopathogenesis of acute myocardial infarction: role of early leukocytosis].
abstract: It has recently been suggested that inflammation may play an important role in the pathogenesis of acute ischemic syndromes. It may therefore be important to relate their clinical features with plasma indexes of inflammation. We have studied leukocyte, platelet and fibrinogen blood levels in 57 consecutive patients with acute myocardial infarction admitted to our Intensive Care Unit within 90 min after the onset of chest pain and treated with primary coronary angioplasty. Patients were divided into two groups on the basis of blood leukocyte levels: Group A, 24 patients, 17 males, mean age 54.2 +/- 13.7 years, with high blood leukocytes and Group B, 33 patients, 28 males, mean age 60.9 +/- 10.3 years, with normal blood leukocytes. Group A patients also had higher serum fibrinogen (p = 0.05) and blood platelet levels (p < 0.05). The stenosis observed after guidewire advancement was significant (> 75%) in 33% of the patients with leukocytosis vs 94% of the others (p < 0.01). No difference between the two groups was observed in the success rate of coronary angioplasty and prevalence of stent placement (100 vs 97%, and 43 vs 42% of the patients of Group A and B, respectively). In contrast, a tendency to rethrombosis requiring Rheopro administration was observed in 62% Group A patients vs 21% Group B patients (p < 0.01). In conclusion, the finding of leukocytosis in the acute phase of myocardial infarction suggests that coronary occlusion is mainly caused by a coronary thrombus occurring at the site of a non significant stenosis. In contrast, when blood leukocytes are normal, the underlying coronary stenosis is more often critical and the thrombotic process is less important. The high blood leukocytes, platelet and fibrinogen levels of Group A patients are consistent with a significant role of inflammation in the pathogenesis of the thrombotic process while hemodynamic and local mechanical factors are probably more important in patients with normal blood leukocytes.
authors.affiliation: Cattedra e Divisione di Cardiologia, Università degli Studi, Brescia.
authors.forename: R
authors.initials: R
authors.lastname: Zanini
authors.forename: S
authors.initials: S
authors.lastname: Curello
authors.forename: L
authors.initials: L
authors.lastname: Bonandi
authors.forename: G
authors.initials: G
authors.lastname: Giovannini
authors.forename: E
authors.initials: E
authors.lastname: Boldi
authors.forename: A
authors.initials: A
authors.lastname: D'Aloia
authors.forename: M
authors.initials: M
authors.lastname: Metra
authors.forename: S
authors.initials: S
authors.lastname: Nodari
authors.forename: L
authors.initials: L
authors.lastname: Dei Cas
mesh_terms: D000328:Adult; D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D017023:Coronary Angiography; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D006439:Hemodynamics; D006801:Humans; D007964:Leukocytosis / Q000150:complications* / Q000175:diagnosis; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood / Q000209:etiology* / Q000628:therapy; D010976:Platelet Count; D015607:Stents; D015912:Thrombolytic Therapy; D013997:Time Factors
chemical_list: D005340:Fibrinogen
vernacular_title: Eziopatogenesi dell'infarto miocardico acuto. Ruolo della leucocitosi precoce.